Skip to main content
. 2022 May 17;16:1483–1493. doi: 10.2147/DDDT.S358092

Figure 4.

Figure 4

Kaplan–Meier curves according to therapeutic regimens. (A) Progression-free survival according to therapeutic regimens (anlotinib monotherapy vs anlotinib and PD-1 blockade combination therapy). (B) Overall survival according to therapeutic regimens (anlotinib monotherapy vs anlotinib and PD-1 blockade combination therapy).